BRIEF published on 11/10/2026 at 14:10, 32 minutes ago The Rainwater Charitable Foundation Supports Neurodegenerative Drug Research Drug Discovery Neurodegenerative Diseases Tau Protein Sprint To Lead Rainwater Charitable Foundation
BRIEF published on 11/10/2026 at 14:10, 32 minutes ago La Fondation caritative Rainwater soutient la recherche sur les médicaments contre les maladies neurodégénératives Maladies Neurodégénératives Découverte De Médicaments Protéine Tau Sprint Pour Prendre La Tête Fondation Caritative Rainwater
PRESS RELEASE published on 11/10/2026 at 14:05, 37 minutes ago Three Researchers Granted Over $1 Million to De-Risk and Progress Preclinical Drug Candidates for Neurodegenerative Diseases
Published on 11/10/2026 at 14:31, 11 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 12 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:00, 42 minutes ago Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
Published on 11/10/2026 at 14:00, 42 minutes ago Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
Published on 11/10/2026 at 14:35, 7 minutes ago K-Beauty at CES: Kolmar Korea Becomes First Company to Win Best of Innovation in Beauty Tech Two Years in a Row
Published on 11/10/2026 at 14:35, 7 minutes ago XLIO Secures Additional $100 Million to Build Startups for Corporate Acquirers
Published on 11/10/2026 at 14:31, 11 minutes ago Knaus Tabbert more than doubles adjusted EBITDA in the first nine months of 2026
Published on 11/10/2026 at 14:05, 37 minutes ago Three Researchers Granted Over $1 Million to De-Risk and Progress Preclinical Drug Candidates for Neurodegenerative Diseases
Published on 11/10/2026 at 14:00, 42 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 2 au 6 novembre 2026
Published on 11/10/2026 at 14:00, 42 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 3 hours 39 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 11:02, 3 hours 39 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 7 hours 42 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
